Physician Perceptions About Parenteral Hydration in Latin America and Spain

January 11, 2019 updated by: M.D. Anderson Cancer Center

Physician Perceptions About Parenteral Hydration in Latin America and Spain: A Survey of Physicians Affiliated With the Latin American Association for Palliative Care (ALCP) and the Spanish Society for Palliative Care (SECPAL)

The purpose of this study is to assess palliative care physicians' attitudes, beliefs and practice patterns related to parenteral hydration at the end of life in Latin America and Spain.

Objectives:

  1. To assess palliative care physicians' attitudes, beliefs and practice patterns related to parenteral hydration at the end of life in Latin America and Spain.
  2. To assess cross-national differences in practice patterns related to parenteral hydration at the end of life. (Latin America vs. Spain).
  3. To determine the percentage of physicians who practice parenteral hydration at the end-of-life in the hospital setting and the home setting.
  4. To examine the association between providers' parenteral hydration practice patterns and:

    • 1. provider demographic characteristics;
    • 2. specific characteristics of their practice settings; and
    • 3. training and experience in end of life care;
  5. To determine which factors most predict the practice of parenteral hydration at the end of life among palliative care physicians.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

This study is a collaboration between MD Anderson's Departments of Palliative care and Rehabilitation Medicine, Health Disparities Research, the Latin American Association for Palliative Care (ALCP) and the Spanish Society for Palliative Care (SECPAL). The proposed study involves a 10-15 minute online survey of palliative care physicians from Latin America and Spain to assess their attitudes, beliefs and practice patterns related to parenteral hydration at the end of life.

Study Type

Observational

Enrollment (Anticipated)

516

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Houston, Texas, United States, 77030
        • Recruiting
        • University of Texas MD Anderson Cancer Center
        • Principal Investigator:
          • Isabel Torres, MPH, DRPH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Physicians affiliated with the Latin American Association for Palliative Care (ALCP) and the Spanish Society for Palliative Care (SECPAL)

Description

Inclusion Criteria:

  1. Palliative care physicians practicing in Latin America and Spain and affiliated with either the ALCP or SECPAL.
  2. Physicians must report dedicating at least 30% of their practice to palliative care.
  3. Physician must be 18 years of age or older.

Exclusion Criteria:

1) None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Online Survey
Survey of Palliative care physicians from Latin America and Spain
10-15 minute online survey to assess palliative care physicians' attitudes, beliefs and practice patterns related to parenteral hydration at the end of life in Latin America and Spain.
Other Names:
  • Questionnaire

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Percentage of terminally ill cancer patients overall that receive an order of parenteral hydration as reported by physicians
Time Frame: Online Survey, completion any time during estimated 2 month period
Online Survey, completion any time during estimated 2 month period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Isabel Torres, MPH, DRPH, M.D. Anderson Cancer Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2010

Primary Completion (Anticipated)

January 1, 2020

Study Completion (Anticipated)

January 1, 2020

Study Registration Dates

First Submitted

November 10, 2009

First Submitted That Met QC Criteria

November 10, 2009

First Posted (Estimate)

November 11, 2009

Study Record Updates

Last Update Posted (Actual)

January 14, 2019

Last Update Submitted That Met QC Criteria

January 11, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dehydration

Clinical Trials on Survey

Subscribe